TEVA announced on July 27th its intention to withdraw its unsolicited expression of interest to acquire rival Mylan N.V., a leading global pharmaceutical company with a growing portfolio of around 1,400 generic pharmaceuticals and brand medications.
A CRA team led by Raphaël De Coninck and including Elina Koustoumpardi, Roman Fischer, Mikaël Hervé, Nitika Bagaria, Guillaume Débarbat, and Ilia Karmanov provided economic support to Mylan in its antitrust defense in front of the European Commission against the attempted hostile take-over.
The effect of platform integration on competition and innovation
Digital companies have profoundly reshaped the economy. They have opened new distribution channels, reorganized supply chains, transformed how businesses reach...